| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/24/2005 | WO2005026346A1 Mammalian host cell of overexpression type for general use |
| 03/24/2005 | WO2005026345A1 Plant dwarfing gene |
| 03/24/2005 | WO2005026342A1 Methods of modulating bone growth, bone remodeling and adiposity |
| 03/24/2005 | WO2005026340A1 Pyrroloquinoline quinone (pqq)-dependent glucose dehydrogenase modification having excellent substrate specificity |
| 03/24/2005 | WO2005026338A1 Alcohol dehydrogenases with increased solvent and temperature stability |
| 03/24/2005 | WO2005026337A2 Adenoviral vector for infecting cells deficient in a car receptor |
| 03/24/2005 | WO2005026332A1 Generation of human embryonic stem cells from triploid zygotes |
| 03/24/2005 | WO2005026331A2 Method of preparation of pharmaceutically grade plasmid dna |
| 03/24/2005 | WO2005026327A2 Biosynthetic gene cluster for leptomycins |
| 03/24/2005 | WO2005026322A2 siRNA ENCODING CONSTRUCTS AND METHODS FOR USING THE SAME |
| 03/24/2005 | WO2005026316A2 Alphavirus vaccines |
| 03/24/2005 | WO2005026314A2 Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same |
| 03/24/2005 | WO2005026253A2 Labile linkage for compound delivery to a cell |
| 03/24/2005 | WO2005026211A2 Anti-ghrelin antibodies |
| 03/24/2005 | WO2005026210A2 Therapeutic binding molecules |
| 03/24/2005 | WO2005026202A1 Compositions comprising a fragment of the herpesviral protein vp22 for delivery of substances to cells |
| 03/24/2005 | WO2005026195A1 Biopanning as an approach to study the pathogenesis of and produce novel treatment modalities for invasive aspergillosis |
| 03/24/2005 | WO2005026188A1 Metal complex type nucleic acid |
| 03/24/2005 | WO2005025624A2 The use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferattive diseases |
| 03/24/2005 | WO2005025601A1 Follistatin isoforms and uses thereof |
| 03/24/2005 | WO2005025590A2 Use of a dg280 protein product for preventing and treating metabolic disorders |
| 03/24/2005 | WO2005025495A2 Methods and compositions for blocking progression of a disease state |
| 03/24/2005 | WO2005025494A2 Vaccine immunotherapy for immune suppressed patients |
| 03/24/2005 | WO2005007855A3 RNA INTERFERENCE MEDIATED INHIBITION OF B7-H1 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 03/24/2005 | WO2005006846A3 Generation of plants with altered oil content |
| 03/24/2005 | WO2005006845A3 Generation of plants with altered oil content |
| 03/24/2005 | WO2005003345A3 Look-through mutagenesis |
| 03/24/2005 | WO2005001087A3 Methods of modifying genes in eukaryotic cells |
| 03/24/2005 | WO2005000215A3 Methods for treating pain |
| 03/24/2005 | WO2004113519A3 Alcohol dehydrogenase sequences useful for developing compounds for the prevention and/or treatment of metabolic diseases |
| 03/24/2005 | WO2004112831A3 High titer recombinant influenza viruses for vaccines and gene therapy |
| 03/24/2005 | WO2004111194A3 Method to increase protein production in culture |
| 03/24/2005 | WO2004111074A9 In vivo production of a clostridial neurotoxin light chain peptide |
| 03/24/2005 | WO2004108893A3 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site |
| 03/24/2005 | WO2004108635A3 Mixed zeaxanthin ester concentrate and uses thereof |
| 03/24/2005 | WO2004106550A3 Identification and/or analysis of nucleic acids and/or proteins associated with a chromosome location |
| 03/24/2005 | WO2004105681A3 Cd4+ human papillomavirus (hpv) epitopes |
| 03/24/2005 | WO2004101766A3 Grp94-based compositions and methods of use thereof |
| 03/24/2005 | WO2004099384A3 Solid phase cell lysis and capture platform |
| 03/24/2005 | WO2004093528A3 Generation of plants with altered oil content |
| 03/24/2005 | WO2004092379A3 Method for treatment of angiogenic disorders |
| 03/24/2005 | WO2004092378A3 Method for treatment of cancerous angiogenic disorders |
| 03/24/2005 | WO2004087952A3 Genes regulated by hydrogen peroxide stress |
| 03/24/2005 | WO2004085463A3 Methods of unnatural amino acid incorporation in proteins in mammalian cells |
| 03/24/2005 | WO2004084815A3 Virulence genes of h. pylori in gastric cancer |
| 03/24/2005 | WO2004083240A3 Regulation of gene expression |
| 03/24/2005 | WO2004081171A3 Variants of enzymes of the alpha-amylase family |
| 03/24/2005 | WO2004079333A3 Method and kit for extracting rna from sputum |
| 03/24/2005 | WO2004078941A3 Modulation of gene expression using dna-rna hybrids |
| 03/24/2005 | WO2004076664A3 Vectors for regulating gene expression |
| 03/24/2005 | WO2004074318A3 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof. |
| 03/24/2005 | WO2004073641A3 Induced activation in dendritic cells |
| 03/24/2005 | WO2004071269A3 Gene marker and composition for diagnosis and treatment of neurological disorders and diseases and use of the same |
| 03/24/2005 | WO2004071178A3 Annexin and p34 promoters and use in expression of transgenic genes in plants |
| 03/24/2005 | WO2004070039A3 Rice promoters |
| 03/24/2005 | WO2004069849A3 Bead emulsion nucleic acid amplification |
| 03/24/2005 | WO2004068931A3 Amphiregulin antibodies and their use to treat cancer and psoriasis |
| 03/24/2005 | WO2004067554A3 Compositions and methods of tolerizing a primate to an antigen |
| 03/24/2005 | WO2004065549A3 Small interference rna gene therapy |
| 03/24/2005 | WO2004065540A3 Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function |
| 03/24/2005 | WO2004052933A3 Peptide oligomers for use as hiv vaccines |
| 03/24/2005 | WO2004047731A3 Modulation of notch3 expression |
| 03/24/2005 | WO2004046336A8 Production of increased oil and protein in plants by the disruption of the phenylpropanoid pathway |
| 03/24/2005 | WO2004044138A3 Chimeric oligomeric compounds and their use in gene modulation |
| 03/24/2005 | WO2004044134A3 Phosphorous-linked oligomeric compounds and their use in gene modulation |
| 03/24/2005 | WO2004043981A3 Nucleic acids and proteins with thioredoxin reductase activity |
| 03/24/2005 | WO2004043979A3 Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 03/24/2005 | WO2004043885A3 Benzoate inducible promoters |
| 03/24/2005 | WO2004041177A3 Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells |
| 03/24/2005 | WO2004041065A3 METHODS FOR PROPHYLAXIS AND TREATMENT OF HER-2/neu TUMORS |
| 03/24/2005 | WO2004029225A3 Detection of modular polyketide synthase gene clusters |
| 03/24/2005 | WO2004024789A8 Phenolic polymer nanotube and process for producing the same |
| 03/24/2005 | WO2004024777A8 Hydroxyalkyl starch derivatives |
| 03/24/2005 | WO2004020637A8 Flavonoid 3',5'hydroxylase gene sequences and uses therefor |
| 03/24/2005 | WO2004016767A3 Evolving new molecular function |
| 03/24/2005 | WO2004012683A9 Novel druggable regions in set domain proteins and methods of using the same |
| 03/24/2005 | WO2003106637A3 Polymeric label molecules |
| 03/24/2005 | WO2003104407A3 T cell receptor cdr3 sequences and methods for detection |
| 03/24/2005 | WO2003103478A3 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs |
| 03/24/2005 | WO2003101176A3 Method, composition and kit for antigenic binding of norwalk-like viruses |
| 03/24/2005 | WO2003094856A3 1l1rl-1 as a cardiovascular disease marker and therapeutic target |
| 03/24/2005 | WO2003087301A8 Methods and compositions for dna manipulation |
| 03/24/2005 | WO2003087134A3 G-protein coupled receptor ligands and methods |
| 03/24/2005 | WO2003080667A3 A novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 03/24/2005 | WO2003072746A3 Subtilisin carlsberg proteins with reduced immunogenicity |
| 03/24/2005 | WO2003062380A3 Multiply-substituted protease variants |
| 03/24/2005 | WO2003060151A3 Novel calpastatin (cast) alleles |
| 03/24/2005 | WO2003045973A8 Peptides with growth inhibitory action |
| 03/24/2005 | WO2003016501A3 Recombinant antibodies, and compositions and methods for making and using the same |
| 03/24/2005 | WO2002092759A9 Molecules for disease detection and treatment |
| 03/24/2005 | WO2002058450A3 Regulation of cell growth by muc1 |
| 03/24/2005 | WO2001068858A8 Human g protein-coupled receptors |
| 03/24/2005 | US20050066396 Casein kinase stress-related polypeptides and methods of use in plants |
| 03/24/2005 | US20050066395 Methods for modification of plant inflorescence architecture |
| 03/24/2005 | US20050066394 Expression vector comprising nucleotide sequences coding flowering locus t (FT) for use as tool in generating plants wijth enhanced shoot and flower development |
| 03/24/2005 | US20050066393 Control of plant flowering time by regulating the expression of phytochrome c |
| 03/24/2005 | US20050066392 Expression vector comprising nucleotide sequences coding which confer a tolerant phenotype in plants in response to chronic and/or acute inhibitin dosages of auxinic herbicides |
| 03/24/2005 | US20050066391 Methods of producing nucleic acids coding for proteins have raffinose synthase activity |
| 03/24/2005 | US20050066390 Nucleotide sequences of a new class of diverged delta-9 stearoyl-ACP desaturase genes |
| 03/24/2005 | US20050066389 Genes which produce staygreen characteristics in maize and their uses |